Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
potential missed dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (was vaccinated with his first dose on 7th March 2019 injected into his right deltoid, Batch Number:gz29l and expiry date :23rd May 2021). On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: potential missed dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 27-MAR-2025 However, current medical records did not show a vaccine was recorded as being administered potential missed dose. Consumer stated he believed it might not had been entered into the system as he was adamant about completing the series. Consumer also stated the provider was physician with. Reporter no longer had that insurance or that doctor as now live in, had been unsuccessful in contacting that doctor. Date and lot number was provided correspond to the first dose administered. Consumer was unable to provide the doctors phone number and address at the time of the call but would obtain the information and call back to update. No further information was obtained/provided. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.